Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIFAMPRIDINE vs REPAGLINIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIFAMPRIDINE vs REPAGLINIDE: Safety Overview

Metric AMIFAMPRIDINE REPAGLINIDE
Total FAERS Reports 2,424 2,544
Deaths Reported 203 169
Death Rate 8.4% 6.6%
Hospitalizations 680 1,517
Average Patient Age 62.5 yrs 71.9 yrs
% Female Patients 62.6% 45.5%
FDA Approval Date Nov 28, 2018 Apr 24, 2015
Manufacturer Catalyst Pharmaceuticals, Inc. Rising Pharma Holdings, Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued